Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Feb;75(2):409-417.
doi: 10.1007/s12020-021-02868-x. Epub 2021 Sep 21.

Association between new markers of cardiovascular risk and hepatic insulin resistance in those at high risk of developing type 2 diabetes

Lucilla D Monti  1   2 , Camillo Bechi Genzano  3 , Barbara Fontana  4 , Elena Galluccio  4 , Serena Spadoni  4 , Andrea Magistro  3 , Emanuele Bosi  3   4 , Piermarco Piatti  3
Affiliations
Observational Study

Association between new markers of cardiovascular risk and hepatic insulin resistance in those at high risk of developing type 2 diabetes

Lucilla D Monti et al. Endocrine. 2022 Feb.

Abstract

Aim/hypothesis: Hepatic insulin resistance (HIR) is considered to be an independent predictor of metabolic disorders and plays an important role in systemic inflammation, which contributes to abnormalities in cardiovascular disease (CVD) risk factors. The aim of this study was to investigate the relationship between HIR and new markers of cardiovascular risks, including leptin/adiponectin ratio (L/A), lipoprotein(a) [Lp(a)], and tumor necrosis factor alpha (TNF-α), at comparable whole body insulin sensitivity in non-diabetic individuals with or without CVD and at high risk of developing type 2 diabetes.

Methods: The HIR index, L/A, Lp(a), and TNF-α were measured in 50 participants with CVD and in 200 without CVD (1:4 ratio). These were also matched for the homeostatic model assessment for insulin resistance (HOMA-IR) and Matsuda-insulin sensitivity index (ISI) in an observational study design.

Results: The HIR index (1.52 ± 0.14 vs. 1.45 ± 0.17, p < 0.02), L/A (3.22 ± 3.10 vs. 2.09 ± 2.27, p < 0.004), and levels of Lp(a) (66.6 ± 49.5 vs. 37.9 ± 3 6.8 mg/dL, p < 0.0001) and TNF-α (18.9 ± 21.8 vs. 5.4 ± 7.1 pg/mL, p < 0.0001) were higher in those with CVD than those without CVD. HOMA-IR and ISI were not significantly different (p = 0.88 and p = 0.35, respectively). The HIR index was directly correlated with L/A (r = 0.41, p < 0.0001), Lp(a) (r = 0.20, p < 0.002), TNF- α (r = 0.14, p < 0.03), and diastolic blood pressure (DBP) (r = 0.13, p < 0.03). The stepwise model analysis showed that L/A, Lp(a), and TNF-α explained about 20% of the variation in the HIR indices of all the participants (p < 0.02).

Conclusions/interpretations: Our results suggest a positive association between HIR and new markers of cardiovascular risk [L/A, Lp(a), and TNF- α] at comparable whole body insulin sensitivity in those with or without CVD and at high risk of developing type 2 diabetes.

Keywords: Adiponectin; Hepatic insulin resistance; Inflammation; Leptin; Lipoprotein(a); Whole body insulin sensitivity.

PubMed Disclaimer

References

    1. G. Reaven, Insulin resistance and coronary heart disease in nondiabetic individuals. Arterioscler Thromb. Vasc. Biol. 32, 1754–9 (2012). https://doi.org/10.1161/ATVBAHA.111.241885 - DOI - PubMed
    1. K.B. Gast, N. Tjeerdema, T. Stijnen, J.W. Smit, O.M. Dekkers, Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS ONE 7, e52036 (2012). https://doi.org/10.1371/journal.pone.0052036 - DOI - PubMed - PMC
    1. M. Stumvoll, S. Jacob, H.G. Wahl, B. Hauer, K. Loblein, P. Grauer, R. Becker, M. Nielsen, W. Renn, H. haring, Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in human. J. Clin. Endocrinol. Metab. 85, 3740–3745 (2000) - PubMed
    1. S. Zhao, C.M. Kusminski, P.E. Scherer, Adiponectin, leptin and cardiovascular disorders. Circ. Res 128, 136–149 (2021). https://doi.org/10.1161/CIRCRESAHA - DOI - PubMed - PMC
    1. J. Zaletel, D.P. Barlovic, J. Prezelj, Adiponectin-leptin ratio: a useful estimate of insulin resistance in patients with Type 2 diabetes. J. Endocrinol. Invest 33, 514–8 (2010). https://doi.org/10.1007/BF03346639 - DOI - PubMed

Publication types

LinkOut - more resources